ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 52 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $303,000 | +4.8% | 280,000 | 0.0% | 0.00% | – |
Q3 2020 | $289,000 | -6.5% | 280,000 | 0.0% | 0.00% | – |
Q2 2020 | $309,000 | -14.2% | 280,000 | -21.1% | 0.00% | – |
Q1 2020 | $360,000 | -55.9% | 355,000 | -50.3% | 0.00% | – |
Q4 2019 | $817,000 | +0.1% | 715,000 | 0.0% | 0.00% | – |
Q3 2019 | $816,000 | -3.4% | 715,000 | 0.0% | 0.00% | – |
Q2 2019 | $845,000 | +1.6% | 715,000 | +16.3% | 0.00% | – |
Q1 2019 | $832,000 | -56.9% | 615,000 | -65.9% | 0.00% | – |
Q4 2018 | $1,931,000 | +1.8% | 1,805,000 | 0.0% | 0.00% | – |
Q3 2018 | $1,896,000 | -5.2% | 1,805,000 | -11.3% | 0.00% | – |
Q2 2018 | $1,999,000 | -0.5% | 2,035,000 | 0.0% | 0.00% | – |
Q1 2018 | $2,010,000 | -6.5% | 2,035,000 | 0.0% | 0.00% | – |
Q4 2017 | $2,149,000 | +14.6% | 2,035,000 | +14.6% | 0.00% | – |
Q3 2017 | $1,875,000 | +23.2% | 1,775,000 | +23.7% | 0.00% | – |
Q2 2017 | $1,522,000 | +57.9% | 1,435,000 | +43.5% | 0.00% | – |
Q1 2017 | $964,000 | – | 1,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STEELHEAD PARTNERS LLC | 52,496,000 | $71,105,000 | 6.72% |
DeepCurrents Investment Group LLC | 47,136,000 | $63,715,000 | 5.52% |
Castle Creek Arbitrage, LLC | 10,734,000 | $14,515,000 | 4.27% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 40,132,000 | $54,451,000 | 3.22% |
Sonora Investment Management, LLC | 17,382,000 | $23,415,000 | 2.87% |
Opti Capital Management, LP | 5,500 | $7,432,000 | 1.99% |
SSI INVESTMENT MANAGEMENT LLC | 13,745,000 | $18,579,000 | 1.56% |
SHENKMAN CAPITAL MANAGEMENT INC | 7,379,000 | $9,994,000 | 1.28% |
Verition Fund Management LLC | 22,795,000 | $30,872,000 | 1.20% |
WOLVERINE ASSET MANAGEMENT LLC | 63,592,000 | $85,986,000 | 1.17% |